Cargando…
Research Progress of Population Pharmacokinetic of Metformin
Metformin is commonly used as first-line treatment for T2DM (type2 diabetes mellitus). Owing to the high pharmacokinetic (PK) variability, several population pharmacokinetic (PPK) models have been developed for metformin to explore potential covariates that affect its pharmacokinetic variation. This...
Autores principales: | Wang, Xiaohu, Tang, Jin, Shen, Chaozhuang, Wang, Xingwen, Hu, Hua, Xie, Haitang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792241/ https://www.ncbi.nlm.nih.gov/pubmed/36578804 http://dx.doi.org/10.1155/2022/4071111 |
Ejemplares similares
-
Physiologically based pharmacokinetic modeling of levetiracetam to predict the exposure in hepatic and renal impairment and elderly populations
por: Shen, Chaozhuang, et al.
Publicado: (2023) -
Predictive performance and verification of physiologically based pharmacokinetic model of propylthiouracil
por: Shen, Chaozhuang, et al.
Publicado: (2022) -
Schisandrin protects against ulcerative colitis by inhibiting the SGK1/NLRP3 signaling pathway and reshaping gut microbiota in mice
por: Wang, Xiaohu, et al.
Publicado: (2023) -
Evaluation of the Influence of Zhenwu Tang on the Pharmacokinetics of Digoxin in Rats Using HPLC-MS/MS
por: Li, Chao, et al.
Publicado: (2021) -
Research Progress on Fatigue Life of Rubber Materials
por: Qiu, Xingwen, et al.
Publicado: (2022)